| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
ABVX
Abivax SA Sponsored ADR
|
Jun 22, 2026 | BUY |
Strong Buy
+18.1% avg upside
15 analysts
|
$135.00
32.72% Upside
|
· |
|
ZYME
Zymeworks
|
Jun 18, 2026 | BUY |
Strong Buy
+39.7% avg upside
25 analysts
|
— | +0.0% |
|
JAZZ
Jazz Pharmaceuticals
|
Jun 18, 2026 | BUY |
Strong Buy
-2.2% avg upside
35 analysts
|
— | +0.0% |
|
GILD
Gilead Sciences
|
Jun 16, 2026 | BUY |
Strong Buy
-5.3% avg upside
66 analysts
|
— | -2.7% |
|
AGIO
Agios Pharma
|
Jun 15, 2026 | BUY |
Strong Buy
+69.5% avg upside
29 analysts
|
$36.00
2.52% Upside
|
· |
|
GMAB
Genmab
|
Jun 12, 2026 | BUY |
Strong Buy
+37.2% avg upside
26 analysts
|
— | · |
|
NUVB
Nuvation Bio
|
Jun 10, 2026 | BUY |
Strong Buy
+127.0% avg upside
15 analysts
|
— | +25.8% |
|
NUVL
Nuvalent
|
Jun 10, 2026 | HOLD |
Buy
-0.2% avg upside
21 analysts
|
$124.00
0.55% Upside
|
+0.0% |
|
NRIX
Nurix Therapeutics
|
Jun 09, 2026 | BUY |
Strong Buy
+66.8% avg upside
26 analysts
|
$32.00
71.66% Upside
|
· |
|
IDYA
IDEAYA Biosciences
|
Jun 02, 2026 | BUY |
Strong Buy
+44.2% avg upside
29 analysts
|
— | +24.3% |
|
FULC
Fulcrum Therapeutics
|
Jun 02, 2026 | HOLD |
Hold
+134.6% avg upside
13 analysts
|
$4.00
6.04% Upside
|
· |
|
ONC
BeOne Medicines
|
Jun 02, 2026 | BUY |
Strong Buy
+27.8% avg upside
28 analysts
|
— | -1.7% |
|
RVMD
Revolution Medicines
|
Jun 01, 2026 | BUY |
Strong Buy
-13.2% avg upside
32 analysts
|
— | -0.4% |
|
MNKD
MannKind
|
Jun 01, 2026 | BUY |
Buy
+80.1% avg upside
22 analysts
|
— | · |
|
VKTX
Viking Therapeutics
|
May 27, 2026 | BUY |
Strong Buy
+129.3% avg upside
30 analysts
|
$83.00
156.42% Upside
|
-6.3% |
|
CGON
CG Oncology, Inc.
|
May 27, 2026 | BUY |
Strong Buy
+33.6% avg upside
17 analysts
|
— | +9.0% |
|
REGN
Regeneron
|
May 18, 2026 | BUY |
Strong Buy
+26.8% avg upside
57 analysts
|
$778.00
26.99% Upside
|
-2.6% |
|
CATX
Perspective Therapeutics
|
May 12, 2026 | BUY |
Strong Buy
+270.9% avg upside
22 analysts
|
— | -22.3% |
|
XNCR
Xencor
|
May 07, 2026 | BUY |
Strong Buy
+144.9% avg upside
27 analysts
|
$29.00
106.93% Upside
|
-8.5% |
|
VRDN
Viridian Therapeutics
|
May 06, 2026 | BUY |
Strong Buy
+93.9% avg upside
32 analysts
|
$35.00
98.54% Upside
|
-8.2% |
|
WAY
Waystar Holding Corp.
|
May 04, 2026 | BUY |
Strong Buy
+113.7% avg upside
29 analysts
|
$38.00
119.54% Upside
|
-11.8% |
|
BCYC
Bicycle Therapeutics
|
May 01, 2026 | HOLD |
Strong Buy
+507.9% avg upside
20 analysts
|
$7.00
75.88% Upside
|
-9.2% |
|
AMGN
Amgen
|
May 01, 2026 | HOLD |
Buy
-12.8% avg upside
57 analysts
|
$327.00
5.20% Downside
|
+6.0% |
|
AAPG
Ascentage Pharma Group International Unsponsored ADR
|
Apr 24, 2026 | BUY |
Strong Buy
+155.8% avg upside
10 analysts
|
$22.34
30.36% Upside
|
-28.1% |
|
ACAD
ACADIA Pharmaceuticals
|
May 19, 2025 | BUY |
Strong Buy
+63.1% avg upside
42 analysts
|
$26.00
17.60% Upside
|
-6.9% |
|
ADCT
ADC Therapeutics
|
May 14, 2025 | BUY |
Buy
+451.8% avg upside
12 analysts
|
$8.00
634.00% Upside
|
+85.6% |
|
EXEL
Exelixis
|
May 13, 2025 | BUY |
Strong Buy
-20.5% avg upside
33 analysts
|
$40.00
22.09% Downside
|
+38.8% |
|
VRCA
Verrica Pharmaceuticals
|
May 13, 2025 | HOLD |
Strong Buy
+223.7% avg upside
8 analysts
|
$20.00
254.71% Upside
|
+34.0% |
|
VSTM
Verastem
|
May 13, 2025 | BUY |
Strong Buy
+251.7% avg upside
23 analysts
|
$16.00
276.54% Upside
|
-36.7% |
|
INO
Inovio Pharmaceuticals
|
May 13, 2025 | HOLD |
Strong Buy
+808.6% avg upside
19 analysts
|
$5.00
350.47% Upside
|
-30.2% |
|
JSPR
Jasper Therapeutics
|
May 12, 2025 | BUY |
Strong Buy
+5846.6% avg upside
17 analysts
|
$46.00
9072.54% Upside
|
-80.7% |
|
PCRX
Pacira Pharmaceuticals
|
May 08, 2025 | HOLD |
Buy
+72.0% avg upside
21 analysts
|
$26.00
14.43% Upside
|
-7.1% |
|
ATYR
aTyr Pharma
|
May 07, 2025 | BUY |
Buy
+1956.5% avg upside
17 analysts
|
$16.00
3302.71% Upside
|
-70.9% |
|
CRMD
Cormedix
|
May 06, 2025 | BUY |
Strong Buy
+70.7% avg upside
13 analysts
|
$13.00
47.33% Upside
|
-27.9% |
|
SPRB
Spruce Biosciences
|
May 06, 2025 | HOLD |
Strong Buy
+84.9% avg upside
14 analysts
|
$37.50
31.43% Downside
|
-85.5% |
|
TSE:APS
Aptose Biosciences
|
Nov 10, 2023 | BUY |
Strong Buy
+4229.1% avg upside
10 analysts
|
$25.50
1103.02% Upside
|
· |
|
AVTX
Avalo Therapeutics
|
Jun 26, 2023 | HOLD |
Strong Buy
+229.5% avg upside
19 analysts
|
$180.00
953.96% Upside
|
-89.1% |
|
APRE
Aprea Therapeutics
|
Mar 16, 2022 | HOLD |
Buy
+2876.6% avg upside
7 analysts
|
$80.00
9980.60% Upside
|
-87.1% |
|
ITRMF
Iterum Therapeutics
|
Nov 12, 2021 | HOLD |
Buy
+18603.6% avg upside
5 analysts
|
$15.00
35957.72% Upside
|
· |
|
BIIB
Biogen
|
Sep 08, 2015 | BUY |
Buy
+23.7% avg upside
51 analysts
|
$348.00
74.26% Upside
|
-0.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.